Computer-aided detection (CAD) firm iCAD has received a patent for its MRI analysis products for breast and prostate cancer detection.
The U.S. Patent and Trademark Office granted the patent, which relates to the speed with which iCAD's image analysis technology pinpoints and marks areas that warrant closer inspection from a radiologist.
iCAD's VividLook, SpectraLook, and OmniLook products utilize this technology for quantitative image analysis for cancer detection, localization, staging, treatment planning, and serial monitoring.
